Compare Roivant Sciences Ltd. Common Shares (ROIV) vs Materials Select Sector SPDR Fund (XLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roivant Sciences Ltd. Common Shares vs Materials Select Sector SPDR Fund — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B), while Materials Select Sector SPDR Fund trades at $49.23 (market cap $7.86B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 3.2× Materials Select Sector SPDR Fund's market cap, and Materials Select Sector SPDR Fund is more actively traded (9,786,394 versus 5,738,571). Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and Materials Select Sector SPDR Fund for 70 Days on average.
| ROIV | XLB | |
|---|---|---|
Market Cap | $25.09B | $7.86B |
Volume | 5,738,571 | 9,786,394 |
Sector | Health | — |
52-Week High | $41.81 | $53.67 |
52-Week Low | $16.04 | $42.23 |
Typical Hold Time | 0 Days | 70 Days |
Enterprise Value | $21.36B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLB trades at $48.98, down 1.51% for the day, with a bearish technical signal from moving averages. The materials sector ETF faces headwinds amid September's broader market weakness outside of technology. Recent analysis indicates the portfolio is heavily concentrated in chemicals (49% of assets) with construction materials appearing moderately overvalued. The fund offers low-cost exposure to large-cap U.S. materials companies but faces cyclical pricing pressures.
The materials sector shows potential from infrastructure and manufacturing trends, though much of the cyclical recovery appears priced in. Key risks include sector concentration, economic sensitivity, and competition from China in critical minerals. Analyst sentiment remains cautious with limited near-term upside potential despite long-term infrastructure tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →About Materials Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: chemicals; metals and mining; paper and forest products; containers and packaging; and construction materials. The fund is non-diversified.
Read more on XLB →
